All sites C00-96,D32-33,D42-43,D45-47,D76 222 87.0 5.5 3.2 0.7 3.5
Mouth, pharynx C00-14 5 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 42 78.9 9.6 6.2 1.4 3.8
  Oesophagus C15 2 60.0 - 20.0 10.0 10.0
  Stomach C16 8 94.9 2.6 - 2.6 -
  Small intestine C17 2 87.5 - 12.5 - -
  Colon C18 11 98.1 - 1.9 - -
  Rectum, rectosigmoid C19-20 8 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 3 50.0 28.6 7.1 - 14.3
  Gallbladder, bile ducts C23-24 1 50.0 16.7 16.7 - 16.7
  Pancreas C25 6 31.3 34.4 21.9 3.1 9.4
  Other digestive organs C26 1 33.3 50.0 - - 16.7
Respiratory organs C30-39 27 66.2 16.5 8.3 0.8 8.3
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 24 62.5 18.3 9.2 0.8 9.2
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 7 100.0 - - - -
Skin, non-melanoma C44 11 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 85.7 - 14.3 - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 67 98.2 - 0.6 0.6 0.6
  Prostate C61 65 98.1 - 0.6 0.6 0.6
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 0 100.0 - - - -
Urinary organs C64-68 22 96.4 0.9 1.8 - 0.9
  Kidney C64 9 93.2 - 4.5 - 2.3
  Bladder and urinary tract2 C65-68 14 98.5 1.5 - - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 5 84.6 - 15.4 - -
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 5 44.0 40.0 4.0 4.0 8.0
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 26 80.2 6.1 1.5 0.8 11.5
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 12 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 3 43.8 12.5 12.5 6.3 25.0
  Leukaemia C91-95 7 79.4 14.7 - - 5.9
  Myelodysplastic syndromes D46 1 57.1 14.3 - - 28.6
  Myeloproliferaitive neoplasms D45,D47 2 12.5 - - - 87.5
Not included above
  Basal cell carcinoma of the skin 50 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.